查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1756396

慢病毒载体市场，按产品类型、按治疗领域、按製造规模、按工作流程阶段、按应用、按国家/地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Lentiviral Vectors Market, By Product Type, By Therapeutic Area, By Manufacturing Scale, By Workflow Stage, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 298 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

慢病毒载体市场规模在 2024 年价值 1.701 亿美元，从 2025 年到 2032 年的复合年增长率为 11.92%。

慢病毒载体市场-市场动态

基因传递系统的进步加速了慢病毒载体的采用

基因递送系统的进步正在加速慢病毒载体在全球治疗和研究领域的应用。美国国家癌症研究所 (NCI) 报告称，慢病毒载体已成为 CAR-T 细胞疗法的基石，多种 FDA 批准的疗法利用这些载体修饰患者的免疫细胞，用于靶向癌症治疗。此外，美国国立卫生研究院 (NIH) 资助了多个旨在提高慢病毒载体安全性和可扩展性的项目，以解决与插入诱变相关的问题。在欧洲，EMA 等监管机构已加快了慢病毒基因疗法的临床试验审批，反映出人们对其潜力日益增长的信心。这些努力凸显了增强型基因传递技术在扩大个人化医疗覆盖范围和推进遗传性疾病和后天性疾病治疗方案的关键作用。

慢病毒载体市场－关键洞察

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 11.92%

根据产品类型细分，慢病毒包装系统预计将在 2024 年占据最大市场份额

根据治疗领域细分，癌症是 2024 年领先的治疗领域

根据生产规模细分，临床级是 2024 年领先的生产规模

根据工作流程阶段细分，病毒包装是 2024 年领先的工作流程阶段

根据应用细分，细胞疗法（例如 CAR-T）是 2024 年领先的应用

按地区划分，北美是 2024 年最大的收入来源

慢病毒载体市场-区隔分析：

全球慢病毒载体市场根据产品类型、治疗领域、製造规模、工作流程阶段、应用和地区进行细分。

根据产品类型，市场分为六类：慢病毒包装系统、慢病毒质粒、客製化慢病毒生产服务、即用型慢病毒、慢病毒启动子和慢病毒融合标籤。慢病毒包装系统因其在载体组装中的作用而占据主导地位；慢病毒质粒对于基因克隆至关重要；定制慢病毒生产服务提供量身定制的解决方案；即用型慢病毒提供便利；慢病毒启动子和融合标籤支持基因表达和蛋白质追踪。

根据治疗领域，市场分为四类：癌症、罕见疾病、传染病和神经系统疾病。由于CAR-T疗法的广泛应用，癌症成为主要治疗领域；罕见疾病受益于个人化基因疗法；传染病在疫苗开发中载体的应用日益增多；随着基因编辑和载体递送研究的不断深入，神经系统疾病正成为新兴治疗目标。

慢病毒载体市场—地理洞察

慢病毒载体市场呈现出明显的区域差异，北美凭藉其完善的生物製药基础设施、雄厚的基因治疗研究资金以及由美国食品药物管理局 (FDA) 主导的支持性监管环境而处于领先地位。美国进行了大量利用慢病毒载体的临床试验，尤其是在CAR-T细胞疗法和罕见遗传疾病领域。欧洲也是重要的参与者，德国、英国和法国等国家大力投资基因疗法创新，并受益于欧洲药品管理局简化的监管途径。在中国、日本和韩国政府加大生物技术和细胞治疗计画的推进力道下，亚太地区正在迅速崛起。这些国家学术机构与生物技术公司之间日益密切的合作，正在加速基于慢病毒载体疗法的临床开发和商业化。同时，拉丁美洲和中东地区正透过建立合作伙伴关係和发展基础设施逐步提升自身能力，专注于解决区域性遗传疾病问题并改善医疗保健服务。

慢病毒载体市场-竞争格局：

慢病毒载体市场的竞争格局由成熟的生物技术公司、新兴的新创公司以及专注于推进基因递送技术的学术研究机构共同塑造。领先的企业正在投资开发更安全、更有效率的慢病毒载体平台，以提高转导效率并降低插入诱变风险。生物製药公司与学术中心之间的策略合作和许可协议十分常见，从而促进了快速创新和临床转化。企业也不断扩大生产能力，以满足对临床级慢病毒载体日益增长的需求，并强调可扩展性和合规性。此外，为了提高疗效，企业纷纷开发新型载体工程技术，例如自灭活载体和标靶递送系统，也加剧了竞争。智慧财产权管理和获得专有技术的独家权利对于保持市场地位并促进这个不断发展的行业的长期成长仍然至关重要。

最新动态：

2024年6月，Charles River Laboratories宣布与科罗拉多大学安舒兹分校盖兹研究所进行策略合作，生产慢病毒载体，加速血液系统癌症的CAR-T细胞疗法开发，并增强先进细胞和基因疗法的製造能力。

2024 年 9 月，Rentschler Biopharma 在其位于英国史蒂夫尼奇的工厂推出了慢病毒载体製造服务，引入了新的 LVV 工具箱来补充现有的 AAV 载体产品，并加速基因和细胞治疗应用（包括罕见疾病和癌症免疫治疗）的先进疗法开发。

2025 年 4 月，ViroCell Biologics 为伦敦大学学院的临床试验生产了 GMP 慢病毒载体，加速了復发性儿童急性淋巴细胞白血病的创新 CAR T 细胞疗法的开发，第一位患者于 2025 年 3 月入组，旨在预防儿童血癌復发。

目录

第一章：慢病毒载体市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 慢病毒载体市场片段（依产品类型）
    • 慢病毒载体市场片段（按治疗领域）
    • 慢病毒载体市场片段（依生产规模）
    • 慢病毒载体市场片段（依工作流程阶段）
    • 慢病毒载体市场片段（按应用）
    • 慢病毒载体市场（按国家/地区）
    • 慢病毒载体市场（按地区）
  • 竞争洞察

第三章：慢病毒载体主要市场趋势

  • 慢病毒载体市场驱动因素
    • 市场驱动因素的影响分析
  • 慢病毒载体市场限制
    • 市场限制的影响分析
  • 慢病毒载体市场机会
  • 慢病毒载体市场未来趋势

第四章：慢病毒载体产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：慢病毒载体市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：慢病毒载体市场格局

  • 慢病毒载体市占率分析（2024年）
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：慢病毒载体市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 慢病毒包装系统
    • 慢病毒质粒
    • 客製化慢病毒生产服务
    • 即用型慢病毒
    • 慢病毒启动子
    • 慢病毒融合标籤

第八章：慢病毒载体市场－依治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 癌症
    • 罕见疾病
    • 传染病
    • 神经系统疾病

第九章：慢病毒载体市场－依生产规模

  • 概述
    • 按製造规模分類的细分市场份额分析
    • 研究级
    • 临床级
    • 商业级

第 10 章：慢病毒载体市场 - 按工作流程阶段

  • 概述
    • 依工作流程阶段进行细分份额分析
    • 质粒构建
    • 病毒包装
    • 纯化与浓缩
    • 品质控制与分析
    • 上游处理
    • 下游加工

第 11 章：慢病毒载体市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 基因治疗
    • 细胞疗法（例如CAR-T）
    • 疫苗研发
    • 功能基因体学

第 12 章：慢病毒载体市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美慢病毒载体主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模及预测（按治疗领域）
    • 北美市场规模及预测（依製造规模）
    • 北美市场规模与预测（按工作流程阶段）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲慢病毒载体主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模及预测（按治疗领域）
    • 欧洲市场规模及预测（依製造规模）
    • 欧洲市场规模与预测（按工作流程阶段）
    • 欧洲市场规模和预测，按应用
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区慢病毒载体主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依治疗领域）
    • 亚太地区市场规模及预测（依製造规模）
    • 亚太地区市场规模及预测（依工作流程阶段）
    • 亚太地区市场规模及预测（按应用）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲慢病毒载体主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按治疗领域）
    • 拉丁美洲市场规模及预测（依製造规模）
    • 拉丁美洲市场规模及预测（依工作流程阶段）
    • LATAM 规模和预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲慢病毒载体主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 中东和非洲市场规模及预测（按製造规模）
    • 中东和非洲市场规模及预测（依工作流程阶段）
    • 中东和非洲市场规模和预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：慢病毒载体产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Aldevron
    • Bio-Techne
    • Cell and Gene Therapy Catapult
    • Charles River Laboratories
    • Creative Biogene
    • ExcellGene SA
    • GeneCopoeia
    • Merck KGaA
    • OriGene Technologies
    • Oxford Biomedica
    • Sartorius AG
    • SIRION Biotech
    • Thermo Fisher Scientific
    • VectorBuilder
    • Vigene Biosciences
    • Wuxi Advanced Therapies
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5351

REPORT HIGHLIGHT

Lentiviral Vectors Market size was valued at US$ 170.10 Million in 2024, expanding at a CAGR of 11.92% from 2025 to 2032.

The Lentiviral Vectors Market involves the development and use of lentivirus-based delivery systems primarily for gene therapy, vaccine development, and research applications. Increasing demand for effective gene delivery methods in treating genetic disorders and cancers has expanded the use of lentiviral vectors, which are favored for their ability to integrate into host genomes and provide stable, long-term gene expression. In 2023, over 60% of gene therapy clinical trials incorporated lentiviral vectors to enhance therapeutic outcomes. However, challenges like high manufacturing costs, biosafety concerns, and potential insertional mutagenesis limit widespread adoption. Advances in vector engineering and scalable production methods offer promising opportunities to improve safety profiles and reduce costs. Additionally, growing investments in CAR-T cell therapies and immunotherapy research present significant avenues for market expansion as lentiviral vectors play a crucial role in modifying immune cells for targeted treatments.

Lentiviral Vectors Market- Market Dynamics

Advancements in gene delivery systems to accelerate lentiviral vector adoption

Advancements in gene delivery systems are accelerating the adoption of lentiviral vectors in therapeutic and research applications worldwide. The National Cancer Institute (NCI) reports that lentiviral vectors have become a cornerstone in CAR-T cell therapies, with several FDA-approved treatments utilizing these vectors to modify patients' immune cells for targeted cancer treatment. Additionally, the U.S. National Institutes of Health (NIH) has funded multiple programs aimed at improving lentiviral vector safety and scalability, addressing concerns related to insertional mutagenesis. In Europe, regulatory agencies such as the EMA have facilitated clinical trial approvals for lentiviral-based gene therapies, reflecting growing confidence in their potential. These efforts underscore the critical role of enhanced gene delivery technologies in expanding the reach of personalized medicine and advancing treatment options for genetic and acquired diseases.

Lentiviral Vectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.92% over the forecast period (2025-2032)

Based on product type segmentation, Lentiviral Packaging Systems was predicted to show maximum market share in the year 2024

Based on Therapeutic Area segmentation, Cancer was the leading Therapeutic Area in 2024

Based on Manufacturing Scale segmentation, Clinical Grade was the leading Manufacturing Scale in 2024

Based on Workflow Stage segmentation, Viral Packaging was the leading Workflow Stage in 2024

Based on Application segmentation, Cell Therapy (e.g., CAR-T) was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Lentiviral Vectors Market- Segmentation Analysis:

The Global Lentiviral Vectors Market is segmented on the basis of Product Type, Therapeutic Area, Manufacturing Scale, Workflow Stage, Application, and Region.

The market is divided into six categories based on product type: Lentiviral Packaging Systems, Lentiviral Plasmids, Custom Lentivirus Production Services, Ready-to-use Lentivirus, Lentiviral Promoter, and Lentiviral Fusion Tags. Lentiviral Packaging Systems dominate due to their role in vector assembly; Lentiviral Plasmids are essential for gene cloning; Custom Lentivirus Production Services offer tailored solutions; Ready-to-use Lentivirus provides convenience; Lentiviral Promoters and Fusion Tags support gene expression and protein tracking.

The market is divided into four categories based on Therapeutic Area: Cancer, Rare Diseases, Infectious Diseases, and Neurological Disorders. Cancer leads as the primary therapeutic area due to extensive CAR-T applications; Rare Diseases benefit from personalized gene therapies; Infectious Diseases see growing vector use for vaccine development; Neurological Disorders are emerging targets with increasing research in gene editing and vector delivery.

Lentiviral Vectors Market- Geographical Insights

The Lentiviral Vectors Market shows significant regional variation, with North America leading due to its well-established biopharmaceutical infrastructure, robust funding for gene therapy research, and supportive regulatory environment led by the FDA. The U.S. hosts numerous clinical trials utilizing lentiviral vectors, particularly in CAR-T cell therapies and rare genetic disorders. Europe is also a key player, with countries like Germany, the UK, and France investing heavily in gene therapy innovation and benefiting from the European Medicines Agency's streamlined regulatory pathways. The Asia-Pacific region is rapidly emerging, driven by increased government initiatives in China, Japan, and South Korea to advance biotechnology and cell therapy programs. Growing collaborations between academic institutions and biotech firms in these countries are accelerating clinical development and commercialization of lentiviral vector-based therapies. Meanwhile, Latin America and the Middle East are gradually expanding their capabilities through partnerships and infrastructure development, focusing on addressing regional genetic disorders and improving healthcare access.

Lentiviral Vectors Market- Competitive Landscape:

The competitive landscape of the Lentiviral Vectors Market is shaped by a combination of established biotechnology companies, emerging startups, and academic research institutions focused on advancing gene delivery technologies. Leading players are investing in the development of safer, more efficient lentiviral vector platforms to improve transduction efficiency and reduce insertional mutagenesis risks. Strategic collaborations and licensing agreements between biopharma companies and academic centers are common, enabling rapid innovation and clinical translation. Companies are also expanding manufacturing capabilities to meet growing demand for clinical-grade lentiviral vectors, emphasizing scalability and regulatory compliance. Additionally, competition is intensified by efforts to develop novel vector engineering techniques, such as self-inactivating vectors and targeted delivery systems, to enhance therapeutic efficacy. Intellectual property management and securing exclusive rights to proprietary technologies remain critical for maintaining market position and fostering long-term growth in this evolving sector.

Recent Developments:

In June 2024, Charles River Laboratories announced a strategic collaboration with the Gates Institute at University of Colorado Anschutz to manufacture lentiviral vectors, accelerating CAR-T cell therapy development for hematological cancers and enhancing advanced cell and gene therapy manufacturing capabilities.

In September 2024, Rentschler Biopharma launched lentiviral vector manufacturing services at its Stevenage, UK facility, introducing a new LVV toolbox to complement existing AAV vector offerings and accelerate advanced therapy development for gene and cell therapy applications, including rare diseases and cancer immunotherapy.

In April 2025, ViroCell Biologics manufactured a GMP lentiviral vector for UCL's clinical trial, accelerating innovative CAR T-cell therapy development for relapsed paediatric acute lymphoblastic leukaemia, with the first patient enrolled in March 2025, aiming to prevent relapse in childhood blood cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LENTIVIRAL VECTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Aldevron
  • Bio-Techne
  • Cell and Gene Therapy Catapult
  • Charles River Laboratories
  • Creative Biogene
  • ExcellGene SA
  • GeneCopoeia
  • Merck KGaA
  • OriGene Technologies
  • Oxford Biomedica
  • Sartorius AG
  • SIRION Biotech
  • Thermo Fisher Scientific
  • VectorBuilder
  • Vigene Biosciences
  • Wuxi Advanced Therapies
  • Others

GLOBAL LENTIVIRAL VECTORS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lentiviral Packaging Systems
  • Lentiviral Plasmids
  • Custom Lentivirus Production Services
  • Ready-to-use Lentivirus
  • Lentiviral Promoter
  • Lentiviral Fusion Tags

GLOBAL LENTIVIRAL VECTORS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Rare Diseases
  • Infectious Diseases
  • Neurological Disorders

GLOBAL LENTIVIRAL VECTORS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032

  • Research Grade
  • Clinical Grade
  • Commercial Grade

GLOBAL LENTIVIRAL VECTORS MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032

  • Plasmid Construction
  • Viral Packaging
  • Purification & Concentration
  • QC & Analytics
  • Upstream Processing
  • Downstream Processing

GLOBAL LENTIVIRAL VECTORS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Gene Therapy
  • Cell Therapy (e.g., CAR-T)
  • Vaccine Development
  • Functional Genomics

GLOBAL LENTIVIRAL VECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Lentiviral Vectors Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lentiviral Vectors Market Snippet by Product Type
    • 2.1.2. Lentiviral Vectors Market Snippet by Therapeutic Area
    • 2.1.3. Lentiviral Vectors Market Snippet by Manufacturing Scale
    • 2.1.4. Lentiviral Vectors Market Snippet by Workflow Stage
    • 2.1.5. Lentiviral Vectors Market Snippet by Application
    • 2.1.6. Lentiviral Vectors Market Snippet by Country
    • 2.1.7. Lentiviral Vectors Market Snippet by Region
  • 2.2. Competitive Insights

3. Lentiviral Vectors Key Market Trends

  • 3.1. Lentiviral Vectors Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lentiviral Vectors Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lentiviral Vectors Market Opportunities
  • 3.4. Lentiviral Vectors Market Future Trends

4. Lentiviral Vectors Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lentiviral Vectors Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Lentiviral Vectors Market Landscape

  • 6.1. Lentiviral Vectors Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lentiviral Vectors Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Lentiviral Packaging Systems
    • 7.1.3. Lentiviral Plasmids
    • 7.1.4. Custom Lentivirus Production Services
    • 7.1.5. Ready-to-use Lentivirus
    • 7.1.6. Lentiviral Promoter
    • 7.1.7. Lentiviral Fusion Tags

8. Lentiviral Vectors Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Rare Diseases
    • 8.1.4. Infectious Diseases
    • 8.1.5. Neurological Disorders

9. Lentiviral Vectors Market - By Manufacturing Scale

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Manufacturing Scale, 2024 & 2032 (%)
    • 9.1.2. Research Grade
    • 9.1.3. Clinical Grade
    • 9.1.4. Commercial Grade

10. Lentiviral Vectors Market - By Workflow Stage

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Workflow Stage, 2024 & 2032 (%)
    • 10.1.2. Plasmid Construction
    • 10.1.3. Viral Packaging
    • 10.1.4. Purification & Concentration
    • 10.1.5. QC & Analytics
    • 10.1.6. Upstream Processing
    • 10.1.7. Downstream Processing

11. Lentiviral Vectors Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 11.1.2. Gene Therapy
    • 11.1.3. Cell Therapy (e.g., CAR-T)
    • 11.1.4. Vaccine Development
    • 11.1.5. Functional Genomics

12. Lentiviral Vectors Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Lentiviral Vectors Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Lentiviral Vectors Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Lentiviral Vectors Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Lentiviral Vectors Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Lentiviral Vectors Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Lentiviral Vectors Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Aldevron
    • 13.2.2. Bio-Techne
    • 13.2.3. Cell and Gene Therapy Catapult
    • 13.2.4. Charles River Laboratories
    • 13.2.5. Creative Biogene
    • 13.2.6. ExcellGene SA
    • 13.2.7. GeneCopoeia
    • 13.2.8. Merck KGaA
    • 13.2.9. OriGene Technologies
    • 13.2.10. Oxford Biomedica
    • 13.2.11. Sartorius AG
    • 13.2.12. SIRION Biotech
    • 13.2.13. Thermo Fisher Scientific
    • 13.2.14. VectorBuilder
    • 13.2.15. Vigene Biosciences
    • 13.2.16. Wuxi Advanced Therapies
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us